Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults (Q34729188)

4 August 2017

title

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults (English)

1 reference

randomized controlled trial

4 August 2017

1 reference

0 references

1 reference

Jiří Beran

1

1 reference

4 August 2017

Mathieu Peeters

2

1 reference

4 August 2017

Walthère Dewé

3

1 reference

4 August 2017

Jolana Raupachová

4

1 reference

4 August 2017

Lenka Hobzová

5

1 reference

4 August 2017

Jeanne-Marie Devaster

6

1 reference

4 August 2017

publication date

20 May 2013

1 reference

4 August 2017

published in

BMC Infectious Diseases

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

page(s)

224

1 reference

Creative Commons Attribution 2.0 Generic

4 August 2017

copyright license

start time

20 May 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The economic value of a quadrivalent versus trivalent influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

The rationale for quadrivalent influenza vaccines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

The need for quadrivalent vaccine against seasonal influenza

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Vaccines for preventing influenza in healthy adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Mortality associated with influenza and respiratory syncytial virus in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-224

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-224

Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-224

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-224

Comparative efficacy of inactivated and live attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-224

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-224

Influenza vaccine effectiveness among elderly nursing home residents: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-224

Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668902

26 October 2018

1 reference

12 December 2020

A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial

1 reference

12 December 2020

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults

1 reference

12 December 2020

1 reference

12 December 2020

Antibody responses to influenza B viruses in immunologically unprimed children

1 reference

12 December 2020

Cross-protection against homologous drift variants of influenza A and B after vaccination with split vaccine

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-13-224

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference